These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17688656)

  • 1. Is the constipated Asian male more common than we think?
    Gwee KA; Wong RK
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1168-9. PubMed ID: 17688656
    [No Abstract]   [Full Text] [Related]  

  • 2. Review article: tegaserod -- the global experience.
    Chey WD
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():15-9. PubMed ID: 15521850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tegaserod in treatment of women with irritable bowel syndrome].
    Munck LK; Ainsworth MA
    Ugeskr Laeger; 2007 Jun; 169(23):2190-2. PubMed ID: 17592683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of tegaserod on work and daily activity in irritable bowel syndrome with constipation.
    Reilly MC; Barghout V; McBurney CR; Niecko TE
    Aliment Pharmacol Ther; 2005 Sep; 22(5):373-80. PubMed ID: 16128674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tegaserod on colonic transit time in male patients with constipation-predominant irritable bowel syndrome.
    Harish K; Hazeena K; Thomas V; Kumar S; Jose T; Narayanan P
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1183-9. PubMed ID: 17688659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tegaserod for constipation-predominant irritable bowel syndrome.
    Kale-Pradhan PB; Wilhelm SM
    Pharmacotherapy; 2007 Feb; 27(2):267-77. PubMed ID: 17253916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A response to Farup and Bytzer. Tegaserod Nordic trial.
    Nyhlin H; Hunt R
    Scand J Gastroenterol; 2004 Aug; 39(8):803-4. PubMed ID: 15513374
    [No Abstract]   [Full Text] [Related]  

  • 8. Irritable bowel syndrome.
    Kennedy T; Rubin G; Jones R
    Clin Evid; 2004 Jun; (11):615-25. PubMed ID: 15652025
    [No Abstract]   [Full Text] [Related]  

  • 9. Desperately seeking serotonin... A commentary on the withdrawal of tegaserod and the state of drug development for functional and motility disorders.
    Pasricha PJ
    Gastroenterology; 2007 Jun; 132(7):2287-90. PubMed ID: 17570201
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacological treatment of irritable bowel syndrome--from concept to sales.
    Kamm MA
    Eur J Surg Suppl; 2002; (587):10-5. PubMed ID: 16144196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. By the way, doctor. I have irritable bowel syndrome, with frequent bloating and constipation. My doctor prescribed a six-week course of Zelnorm, which really helped. Is it safe to take long-term?
    Robb-Nicholson C
    Harv Womens Health Watch; 2005 May; 12(9):8. PubMed ID: 16047399
    [No Abstract]   [Full Text] [Related]  

  • 12. New options for soothing an irritable bowel.
    Johns Hopkins Med Lett Health After 50; 2004 Mar; 16(1):4-5. PubMed ID: 15029867
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacoeconomics and outcome research on Irritable Bowel Syndrome review of findings using Tegaserod].
    Ariza JG; Martínez JA
    Rev Gastroenterol Peru; 2006; 26(1):77-9. PubMed ID: 16622489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy for irritable bowel syndrome.
    Lacy BE
    N Engl J Med; 2004 Mar; 350(12):1261-3; author reply 1261-3. PubMed ID: 15031865
    [No Abstract]   [Full Text] [Related]  

  • 15. Irritable bowel syndrome.
    de Wit N; Rubin G; Jones R
    Clin Evid; 2005 Jun; (13):556-63. PubMed ID: 16135274
    [No Abstract]   [Full Text] [Related]  

  • 16. [New drug for irritable bowel syndrome].
    Hennemann A
    Med Monatsschr Pharm; 2001 Apr; 24(4):106-8. PubMed ID: 11338633
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment experience of patients with irritable bowel syndrome complicated by constipations with medicinal preparation softovak].
    Ruchkina IN; Lychkova AE; Parfenov AI
    Eksp Klin Gastroenterol; 2007; (5):103-6. PubMed ID: 18389606
    [No Abstract]   [Full Text] [Related]  

  • 18. New drug for women with irritable bowel syndrome.
    Mayo Clin Health Lett; 2003 Dec; 21(12):4. PubMed ID: 14971349
    [No Abstract]   [Full Text] [Related]  

  • 19. Tegaserod in patients with irritable bowel syndrome.
    Schooff M; Stelter C
    Am Fam Physician; 2004 Dec; 70(11):2107-8. PubMed ID: 15606056
    [No Abstract]   [Full Text] [Related]  

  • 20. New drug approved for irritable bowel syndrome in women.
    Mayo Clin Womens Healthsource; 2004 Feb; 8(2):3. PubMed ID: 14722489
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.